Hyperamylasemia in ovarian tumours - serum amylase as a marker for ovarian cancers (?)

International Journal of Pharma and Bio Sciences

Volumn 2, Issue 1, 2011, Pages 445-449

  D'Souza, Benedicta ^a   Sreekantha, ^a   D'Souza, Vivian ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

Author keywords

Ovarian cyst; Ovarian tumour; Serum amylase

Indexed keywords

AMYLASE; TUMOR MARKER;

ADULT; AGED; AMYLASE BLOOD LEVEL; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; HUMAN; HYPERAMYLASEMIA; MAJOR CLINICAL STUDY; OVARY CANCER; OVARY CYST; OVARY TUMOR;

EID: 79961061167     PISSN: None     EISSN: 09756299     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Fauci, Braunwald, Isselbacher, Wilson, et al. Harrison's Principles of Internal Medicine 2002; 1:605-608.
2. Vanvi, Maxwell, Revamen. Gastroenterology. 2003;12:408-409.
3. Pieper Bigelow C, Strocchi A, Levitt MD. Where does serum amylase come from and where does it go? Clin chem. 1976;22(4):439-44.
4. Takeuchi T, Fujiki H, Kameya T. Characterisation of amylases produced by tumors. Chin chem. 1981;27(4):556-9.
5. Tetsuo Hayakawa, Akira Kameya, Ribun Mizuno, Aiji Noda, Takaharu Kondo, Norio Hirabayashi. Hyperamylasemia with papillary serous cystadenocarcinoma of the Ovary. Cancer. 1984;54:1662-65.
6. Masatoshi Ueda, Michio Kobayashi, Kazuhisa Taketa, Jiro Sato V. Ectopic production of a salivary type Amylase by Adenocarcinoma cells: Demonstration by culture technique.Clinica Chimica Acta. 1977;80:105-111.
7. John A, Papalas Drive, Lindon Park.Michigan USA 2005.Liquid Amylase (NPG3) Reagent set. Pointe Scientific INC. 1025.
8. Harold Van Kely, Stewart Cramer, David E. Bruns Serous Ovarian Neoplastic Amylase (SONA): A potentially useful marker for serous ovarian tumour. Cancer. 1981;48:1444-49.
9. Landis SH, Myrray T, Boldens, Wingo PA. Cancer Statistics (published erratum) Cancer J. clin. 1998;48:192.
10. Roberta B, Ness, Carrie Cottreau. Possible role of ovarian epithelial inflammation in Ovarian cancer. J. Natl Cancer Inst. 1999;91:1459-67.
11. Kunihide Gomi, Toru Kameya, Masaru Tsumuraya, Yukio Shimosato, Fujio Zeze, Kaoru Abe, Takeshi Yoneyama. Ultrastructural, Histochemical and Biochemical studies of two cases with amylase, ACTH and beta-MSH producing tumour. Cancer. 1976;38:1645-54.
12. Marvin B, Corlette, Marris Dratch, Karl Sorger. Amylase elevation attributable to ovarian neoplasm. Gastroenterology. 1978;74:907-9.
13. Scott H. Noorwood, Michael J. Torma, Larry J. Fontenelle Hyperamylasemia due to poorly differentiated Adenosquamatous Carcinoma of the ovary. Arch Surg. 1981;116:225-26.
14. Charles M. Bagley, Robert C. young, George P. Canellos, Vincent T. Devita. Treatment of Ovarian Carcinoma: possibilities of progress. N. Eng. J. Med. 1972;287:856-62.
15. Vincent T. Devita, Todd H. Warserman, Robert Young, Stephen. Prospectives on Research in Gynaecologic oncology and treatment protocols. Cancer. 1976;38:509-525.
16. Luca Frulloni, Franca Patrizi, Laura Bernardoni, Giorgio Cavallini. Pancreatic Hyperenzymemia: clinical significance and diagnostic Approach. JOP. J. Pancreas. 2005;6(6):536-551.
17. Henriksen R, Brock A. Amylase activity and fast migrating amylase in serum and cyst fluid from patients with ovarian Neoplasm. Acta obst gynae scand. 1988;67(1):65-70.